yulu song

Dr. yulu song


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2024 in Autism Research
Verified
Journal Article
Closed access
YSyulu song
yulu song
KHKathleen E. Hupfeld
Kathleen E. Hupfeld
CDChristopher W. Davies‐Jenkins
Christopher W. Davies‐Jenkins
HZHelge J. Zöllner
Helge J. Zöllner
SMSaipavitra Murali‐Manohar
Saipavitra Murali‐Manohar
RERichard A. E. Edden
Richard A. E. Edden

22 October 2020 in Neurochemistry International
Verified
Journal Article
Closed access
TGTao Gong
Tao Gong
XZXia Zhang
Xia Zhang
XWXinhong Wei
Xinhong Wei
SYShuhui Yuan
Shuhui Yuan
MSMuhammad G. Saleh
Muhammad G. Saleh
GWGuangbin Wang
Guangbin Wang

31 May 2024 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
CDChristopher W. Davies‐Jenkins
Christopher W. Davies‐Jenkins
HZHelge J. Zöllner
Helge J. Zöllner
DSDunja Simicic
Dunja Simicic
SHSteve C. N. Hui
Steve C. N. Hui
YSyulu song
yulu song
GOGeorg Oeltzschner
Georg Oeltzschner

29 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
YSyulu song
yulu song
KHKathleen E. Hupfeld
Kathleen E. Hupfeld
CDChristopher W. Davies-Jenkins
Christopher W. Davies-Jenkins
HZHelge J. Zöllner
Helge J. Zöllner
SMSaipavitra Murali-Manohar
Saipavitra Murali-Manohar
RERichard A.E. Edden
Richard A.E. Edden
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication challenges and repetitive behaviors. Altered neurometabolite levels, including glutathione (GSH) and gamma-aminobutyric acid (GABA), have been proposed as potential contributors to the biology underlying ASD. This study investigated whether cerebral GSH or GABA levels differ between a large cohort of children aged 8-12 years with ASD (n=52) and typically developing children (TDC, n=49). A comprehensive analysis of GSH and GABA levels in multiple brain regions, including the primary motor cortex (SM1), thalamus (Thal), medial prefrontal cortex (mPFC), and supplementary motor area (SMA), was conducted using single-voxel HERMES MR spectroscopy at 3T. The results revealed no significant differences in cerebral GSH or GABA levels between the ASD and TDC groups across all examined regions. These findings suggest that the concentrations of GSH (an important antioxidant and neuromodulator) and GABA (a major inhibitory neurotransmitter) do not exhibit marked alterations in children with ASD compared to TDC. A statistically significant positive correlation was observed between GABA levels in the SM1 and Thal regions with ADHD inattention scores. No significant correlation was found between metabolite levels and hyper/impulsive scores of ADHD, measures of core ASD symptoms (ADOS-2, SRS-P) or adaptive behavior (ABAS-2). While both GSH and GABA have been implicated in various neurological disorders, the current study provides valuable insights into the specific context of ASD and highlights the need for further research to explore other neurochemical alterations that may contribute to the pathophysiology of this complex disorder. Lay summary: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication challenges and repetitive behaviors. Altered glutathione (GSH, an important antioxidant and neuromodulator) and gamma-aminobutyric acid (GABA, a major inhibitory neurotransmitter) levels have been proposed as potential contributors to the biology underlying ASD. Here, we used advanced edited Magnetic Resonance Spectroscopy (MRS) to measure levels of these low-concentration metabolites in four brain regions of a pediatric cohort. Contrary to our hypothesis, no significant difference was found between ASD and control subjects in either GSH or GABA levels in any brain region.

8 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAaron T. Gudmundson
Aaron T. Gudmundson
CDChristopher W. Davies-Jenkins
Christopher W. Davies-Jenkins
İÖİpek Özdemir
İpek Özdemir
SMSaipavitra Murali-Manohar
Saipavitra Murali-Manohar
HZHelge J. Zöllner
Helge J. Zöllner
RERichard A. E. Edden
Richard A. E. Edden
Neural networks are potentially valuable for many of the challenges associated with MRS data. The purpose of this manuscript is to describe the AGNOSTIC dataset, which contains 259,200 synthetic 1 H MRS examples for training and testing neural networks. AGNOSTIC was created using 270 basis sets that were simulated across 18 field strengths and 15 echo times. The synthetic examples were produced to resemble in vivo brain data with combinations of metabolite, macromolecule, residual water signals, and noise. To demonstrate the utility, we apply AGNOSTIC to train two Convolutional Neural Networks (CNNs) to address out-of-voxel (OOV) echoes. A Detection Network was trained to identify the point-wise presence of OOV echoes, providing proof of concept for real-time detection. A Prediction Network was trained to reconstruct OOV echoes, allowing subtraction during post-processing. Complex OOV signals were mixed into 85% of synthetic examples to train two separate CNNs for the detection and prediction of OOV signals. AGNOSTIC is available through Dryad and all Python 3 code is available through GitHub. The Detection network was shown to perform well, identifying 95% of OOV echoes. Traditional modeling of these detected OOV signals was evaluated and may prove to be an effective method during linear-combination modeling. The Prediction Network greatly reduces OOV echoes within FIDs and achieved a median log 10 normed-MSE of –1.79, an improvement of almost two orders of magnitude.

14 October 2025 in International Journal of Eating Disorders
Verified
Journal Article
Closed access
YSyulu song
yulu song
SGSarah H. Guo
Sarah H. Guo
CDChristopher W. Davies‐Jenkins
Christopher W. Davies‐Jenkins
AGAngela Sarah Guarda
Angela Sarah Guarda
RERichard A. E. Edden
Richard A. E. Edden
KSKimberly Smith
Kimberly Smith